Recipient
Heaton Moor Medical Group
First report 14 Mar 2018•Latest report 19 Sep 2019
Reports, concerns and published responses
Health and care · Healthcare site. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
- Reports
- 2
- Published responses
- 0%
- Concerns addressed
- 0
- Stated actions
- 0
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from Heaton Moor Medical Group linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised3
Failure to verify mental health service advice before prescribing Diazepam
Failure to review the approach to prescribing Diazepam
Failure to assess illicit access to Diazepam
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
-
Concerns raised3
Lack of consistent and clear prescribing guidance across local and national lists
Risk of patients obtaining melatonin from unlicensed internet sources
Failure to communicate with community GPs before discharge about ongoing melatonin prescribing
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026